HILIC for Released Glycans

Representative Performance from the First Injection

ACQUITY Premier Glycan BEH Amide Columns with MaxPeak High Performance Surfaces (HPS) Technology, that reduces sample loss caused by non-specific adsorption on metal surfaces, deliver the representative performance of Glycan BEH Amide chemistry from the first injection.

• No conditioning or passivation
• Save time and reagents
• Reduce variability of retention time and peak response
• Improve recovery of the phosphorylated glycans  

Released N-Glycan Columns

Waters ACQUITY UPLC and XBridge Glycan BEH Amide 130 Å Columns are best suited for the analysis of released, N-labeled glycans using pre-column labeling with 2-AB, 2-AA, or Waters innovative and enabling RapiFluor-MS reagent. Each batch our Glycan BEH Amide 130 Å chemistry is specifically QC tested with a complex mixture of 2-AB labeled glycans from a mAb digest to help ensure consistent column performance in validated methods.

The image to the right shows the N-linked glycans from pooled human IgG contain high mannose as well as neutral, and sialylated complex structures. The chromatogram shows 35 minutes of a one hour analysis. This challenging sample includes high mannose, bisecting GlcNAc and sialylated species.

Scalability

Shown to the right is the performance of HILIC glycan columns varying in particle size at the same linear velocity.